Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

Clinical trial NCT07534033 · RECRUITING

Trial details

NCT number: NCT07534033
Sponsor: Zhujiang Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Diagnosed by Histology or Cytology A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection Overall Lung Function is Adequate for the Planned Lung Resection AJCC is Classified as IB-IIIC

Start date: 2025-12-06
Primary completion: 2026-12-23
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.